Biogen Inc. (BIIB) stock analysis
In our weekly check, Biogen Inc. is graded C (A to F). Of 24 checks on debt, profit, cash flow and trend: 12 pass, warnings: 7, red flags: 5.
About Biogen Inc.
Biogen Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NASDAQ as BIIB.
What our checks show for BIIB
Red flags
- The net margin fell by 10.8 points over 5 years, to 3.4%: the company keeps less of each sale as profit.
- The gross margin fell by 10.7 points, to 70%: costs are rising faster than prices.
- The net margin is only 3.4%: little room if costs rise.
- The stock has fallen as much as 76% from a peak. Would you have held through that?
- Return on capital (ROCE) is only 2.8%.
Warning signs
- Net debt is 4.5x a year of EBITDA (debt/equity 0.41). That limits room in a downturn and raises refinancing risk.
- Operating profit covers interest only 2.6 times: a weak year could make the payments hard.
- Analysts expect only about 3.5% a year of growth in revenue.
- Revenue grew only 0.4% a year over the last 3 years.
- Earnings per share fell 51.7% a year over the last 3 years.
- Net profit fell 51.5% a year over the last 3 years.
- The stock is still below its previous peak.
Strengths
- Operating cash flow is 6.46x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 149% a year over the next years.
- Analysts expect the net margin to improve by 21 points from today's 3.4%.
- Free cash flow is 20% of revenue: cash for dividends, buybacks or growth.
- A large company: market value $37.46 billion.
- Beta 0.17: the stock usually moves less than the market.
Next earnings report: 2027-02-05
Similar companies
GSK · SNY · BMY · PFE · NVO · GILD
Questions
What grade does Biogen Inc. (BIIB) have?
In our weekly check, Biogen Inc. is graded C (A to F). Of 24 checks on debt, profit, cash flow and trend: 12 pass, warnings: 7, red flags: 5. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of BIIB stock?
This week's biggest flags for Biogen Inc.: Margins falling, Gross margin falling, Thin margins. In total 12 of 24 checks show a warning or a red flag.
What does Biogen Inc. do?
Biogen Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NASDAQ as BIIB.
When does Biogen Inc. report earnings next?
The next earnings report is expected on 2027-02-05. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis